SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the September 2023 quarter moved up 25.14% to Rs. 965.76 millions as compared to Rs. 771.77 millions during the corresponding quarter last year.A comparatively good net profit growth of 34.97% to Rs. 183.78 millions was reported for the quarter ended September 2023 compared to Rs. 136.16 millions of previous same quarter.OP of the company witnessed a marginal growth to 274.03 millions from 209.46 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 965.76 771.77 25.14 1819.25 1492.87 21.86 3115.29 2727.98 14.20
Other Income 7.85 20.00 -60.75 520.34 32.45 1503.51 98.08 90.80 8.02
PBIDT 274.03 209.46 30.83 1034.29 336.59 207.28 846.96 817.28 3.63
Interest 0.33 0.26 26.92 0.68 0.54 25.93 1.35 0.95 42.11
PBDT 273.70 209.20 30.83 1033.61 336.05 207.58 845.61 816.33 3.59
Depreciation 26.09 25.07 4.07 51.16 49.16 4.07 102.83 95.61 7.55
PBT 247.61 184.13 34.48 982.45 286.89 242.45 742.78 720.72 3.06
TAX 63.83 47.97 33.06 123.80 72.95 69.71 187.51 175.61 6.78
Deferred Tax -2.32 0.77 -401.30 -3.00 -0.31 867.74 4.97 -4.56 -208.99
PAT 183.78 136.16 34.97 858.65 213.94 301.35 555.27 545.11 1.86
Equity 223.65 223.64 0.00 223.65 223.64 0.00 223.65 223.60 0.02
PBIDTM(%) 28.37 27.14 4.55 56.85 22.55 152.16 27.19 29.96 -9.25

Advanced Enzyme Share Price

299.00 -8.95 (-2.91%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×